Barclays’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Barclays’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,164	Closed	-$50K	–	5453
2023 Q3	$50K	Sell	1,164 -4,663,776	-100%	-$198M	﹤0.01%	3871
2023 Q2	$197M	Buy	4,664,940 +1,604,446	+52%	+$64.9M	0.12%	161
2023 Q1	$109M	Buy	3,060,494 +2,500,323	+446%	+$90.7M	0.05%	248
2022 Q4	$20.5M	Buy	560,171 +525,043	+1,495%	+$20.8M	0.01%	880
2022 Q3	$1.66M	Sell	35,128 -12,108	-26%	-$782K	﹤0.01%	1883
2022 Q2	$3.39M	Sell	47,236 -54,764	-54%	-$4M	﹤0.01%	1534
2022 Q1	$8.26M	Buy	102,000 +4,593	+5%	+$389K	0.01%	981
2021 Q4	$10M	Sell	97,407 -39,655	-29%	-$3.81M	﹤0.01%	1272
2021 Q3	$12M	Sell	137,062 -13,763	-9%	-$1.25M	0.01%	1098
2021 Q2	$13.5M	Buy	150,825 +48,288	+47%	+$4.08M	0.01%	1070
2021 Q1	$7.78M	Buy	102,537 +20,822	+25%	+$1.57M	﹤0.01%	1203
2020 Q4	$5.57M	Sell	81,715 -13,851	-14%	-$864K	﹤0.01%	1457
2020 Q3	$5.08M	Sell	95,566 -206	-0.2%	-$12.3K	﹤0.01%	1385
2020 Q2	$5.58M	Sell	95,772 -51,229	-35%	-$2.75M	﹤0.01%	1296
2020 Q1	$5.79M	Sell	147,001 -46,092	-24%	-$2.7M	﹤0.01%	1352
2019 Q4	$11.5M	Buy	193,093 +145,607	+307%	+$7.83M	0.01%	1289
2019 Q3	$2.53M	Sell	47,486 -3,901	-8%	-$200K	﹤0.01%	2582
2019 Q2	$2.62M	Buy	51,387 +22,270	+76%	+$1.04M	﹤0.01%	2594
2019 Q1	$1.51M	Sell	29,117 -2,932	-9%	-$142K	﹤0.01%	2918
2018 Q4	$1.26M	Sell	32,049 -53,883	-63%	-$2.5M	﹤0.01%	2885
2018 Q3	$4.43M	Buy	85,932 +38,916	+83%	+$1.91M	﹤0.01%	1935
2018 Q2	$2.21M	Sell	47,016 -55,734	-54%	-$2.31M	﹤0.01%	2499
2018 Q1	$3.65M	Buy	102,750 +22,671	+28%	+$888K	﹤0.01%	1884
2017 Q4	$3.49M	Buy	80,079 +39,423	+97%	+$1.84M	﹤0.01%	1935
2017 Q3	$2.13M	Sell	40,656 -32,383	-44%	-$1.81M	﹤0.01%	2283
2017 Q2	$4.27M	Sell	73,039 -63,756	-47%	-$3.31M	﹤0.01%	1589
2017 Q1	$6.27M	Buy	136,795 +33,954	+33%	+$1.69M	0.01%	1183
2016 Q4	$5.41M	Buy	102,841 +99,516	+2,993%	+$4.82M	0.01%	1337
2016 Q3	$147K	Buy	3,325 +2,312	+228%	+$100K	﹤0.01%	4218
2016 Q2	$38K	Sell	1,013 -10,754	-91%	-$472K	﹤0.01%	4988
2016 Q1	$482K	Sell	11,767 -39,617	-77%	-$1.63M	﹤0.01%	3179
2015 Q4	$2.47M	Buy	51,384 +51,316	+75,465%	+$2.28M	﹤0.01%	1855
2015 Q3	$3K	Sell	68 -180	-73%	-$7.86K	﹤0.01%	6254
2015 Q2	$10K	Sell	248 -31	-11%	-$1.07K	﹤0.01%	6108
2015 Q1	$8K	Sell	279 -251	-47%	-$6.93K	﹤0.01%	6370
2014 Q4	$13K	Buy	+530	New	+$12.6K	﹤0.01%	6582

Other funds holding SYNH

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's SYNH Position: Q4 2023 in Review

Barclays sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2023, closing a stake of 1,164 shares — an estimated $50K sold.

Barclays first reported a position in SYNH in Q4 2014 and held it in 36 quarters. The position peaked at $197M in Q2 2023. 2 funds tracked by Wall St. Rank hold SYNH as of Q4 2023.

Barclays reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Barclays sold 1,164 Syneos Health, Inc. Class A Common Stock shares in Q4 2023, an estimated $50K.
Barclays first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 36 quarters.
Barclays's Syneos Health, Inc. Class A Common Stock position peaked at $197M in Q2 2023.
2 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.